Pharmacokinetics and postmortem changes of cimetidine in body tissues

T. Imamura, T. Nagata, K. Kimura, Keiko Kudo, N. Urakawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Cimetidine concentrations in body tissues were pharmacokinetically examined, together with their postmortem changes, to assess the toxicological effect of this drug from the aspect of forensic medicine. For the pharmacokinetic study, rats were pithed at 0.5, 1.0, 2.0, 4.0 or 8.0 hours after an intravenous injection of the drug (33.3 mg/kg), and their tissue samples were immediately collected to be analyzed hy high-performance liquid chromatography (HPLC). The concentrations of cimetidine in the blood and muscle decreased below the lower detection limit at 8 hours after the injection, while the drug could still be detected in the brain, lung, liver, kidney, spleen and adipose tissue. The ratios of the cimetidine concentrations in the muscle, lung and spleen to that in the blood were nearly constant until 4 hours after the injection, while those in the liver, kidney and adipose tissue increased as time elapsed. Postmortem changes of cimetidine concentrations were examined using the tissue samples collected 0, 1 and 2 days after death. There was no statistical significance in the postmortem changes in cimetidine concentrations in the body tissues over the two-day period of examination. The experimental results indicated that the muscle, lung and spleen together can serve as samples for toxicological analysis to evaluate the effect of cimetidine, regardless of various postmortem factors, including the availability of blood.

Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalJapanese Journal of Legal Medicine
Volume48
Issue number2
Publication statusPublished - Jan 1 1994

Fingerprint

Postmortem Changes
Cimetidine
Pharmacokinetics
Spleen
Muscles
Lung
Toxicology
Adipose Tissue
Pharmaceutical Preparations
Kidney
Injections
Forensic Medicine
Liver
Intravenous Injections
Limit of Detection
High Pressure Liquid Chromatography
Brain

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Law

Cite this

Imamura, T., Nagata, T., Kimura, K., Kudo, K., & Urakawa, N. (1994). Pharmacokinetics and postmortem changes of cimetidine in body tissues. Japanese Journal of Legal Medicine, 48(2), 75-78.

Pharmacokinetics and postmortem changes of cimetidine in body tissues. / Imamura, T.; Nagata, T.; Kimura, K.; Kudo, Keiko; Urakawa, N.

In: Japanese Journal of Legal Medicine, Vol. 48, No. 2, 01.01.1994, p. 75-78.

Research output: Contribution to journalArticle

Imamura, T, Nagata, T, Kimura, K, Kudo, K & Urakawa, N 1994, 'Pharmacokinetics and postmortem changes of cimetidine in body tissues', Japanese Journal of Legal Medicine, vol. 48, no. 2, pp. 75-78.
Imamura T, Nagata T, Kimura K, Kudo K, Urakawa N. Pharmacokinetics and postmortem changes of cimetidine in body tissues. Japanese Journal of Legal Medicine. 1994 Jan 1;48(2):75-78.
Imamura, T. ; Nagata, T. ; Kimura, K. ; Kudo, Keiko ; Urakawa, N. / Pharmacokinetics and postmortem changes of cimetidine in body tissues. In: Japanese Journal of Legal Medicine. 1994 ; Vol. 48, No. 2. pp. 75-78.
@article{3bcaba4fffe34ed7839dbc73790e6fe8,
title = "Pharmacokinetics and postmortem changes of cimetidine in body tissues",
abstract = "Cimetidine concentrations in body tissues were pharmacokinetically examined, together with their postmortem changes, to assess the toxicological effect of this drug from the aspect of forensic medicine. For the pharmacokinetic study, rats were pithed at 0.5, 1.0, 2.0, 4.0 or 8.0 hours after an intravenous injection of the drug (33.3 mg/kg), and their tissue samples were immediately collected to be analyzed hy high-performance liquid chromatography (HPLC). The concentrations of cimetidine in the blood and muscle decreased below the lower detection limit at 8 hours after the injection, while the drug could still be detected in the brain, lung, liver, kidney, spleen and adipose tissue. The ratios of the cimetidine concentrations in the muscle, lung and spleen to that in the blood were nearly constant until 4 hours after the injection, while those in the liver, kidney and adipose tissue increased as time elapsed. Postmortem changes of cimetidine concentrations were examined using the tissue samples collected 0, 1 and 2 days after death. There was no statistical significance in the postmortem changes in cimetidine concentrations in the body tissues over the two-day period of examination. The experimental results indicated that the muscle, lung and spleen together can serve as samples for toxicological analysis to evaluate the effect of cimetidine, regardless of various postmortem factors, including the availability of blood.",
author = "T. Imamura and T. Nagata and K. Kimura and Keiko Kudo and N. Urakawa",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "48",
pages = "75--78",
journal = "Japanese Journal of Legal Medicine",
issn = "0047-1887",
publisher = "Medico-Legal Society of Japan",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetics and postmortem changes of cimetidine in body tissues

AU - Imamura, T.

AU - Nagata, T.

AU - Kimura, K.

AU - Kudo, Keiko

AU - Urakawa, N.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Cimetidine concentrations in body tissues were pharmacokinetically examined, together with their postmortem changes, to assess the toxicological effect of this drug from the aspect of forensic medicine. For the pharmacokinetic study, rats were pithed at 0.5, 1.0, 2.0, 4.0 or 8.0 hours after an intravenous injection of the drug (33.3 mg/kg), and their tissue samples were immediately collected to be analyzed hy high-performance liquid chromatography (HPLC). The concentrations of cimetidine in the blood and muscle decreased below the lower detection limit at 8 hours after the injection, while the drug could still be detected in the brain, lung, liver, kidney, spleen and adipose tissue. The ratios of the cimetidine concentrations in the muscle, lung and spleen to that in the blood were nearly constant until 4 hours after the injection, while those in the liver, kidney and adipose tissue increased as time elapsed. Postmortem changes of cimetidine concentrations were examined using the tissue samples collected 0, 1 and 2 days after death. There was no statistical significance in the postmortem changes in cimetidine concentrations in the body tissues over the two-day period of examination. The experimental results indicated that the muscle, lung and spleen together can serve as samples for toxicological analysis to evaluate the effect of cimetidine, regardless of various postmortem factors, including the availability of blood.

AB - Cimetidine concentrations in body tissues were pharmacokinetically examined, together with their postmortem changes, to assess the toxicological effect of this drug from the aspect of forensic medicine. For the pharmacokinetic study, rats were pithed at 0.5, 1.0, 2.0, 4.0 or 8.0 hours after an intravenous injection of the drug (33.3 mg/kg), and their tissue samples were immediately collected to be analyzed hy high-performance liquid chromatography (HPLC). The concentrations of cimetidine in the blood and muscle decreased below the lower detection limit at 8 hours after the injection, while the drug could still be detected in the brain, lung, liver, kidney, spleen and adipose tissue. The ratios of the cimetidine concentrations in the muscle, lung and spleen to that in the blood were nearly constant until 4 hours after the injection, while those in the liver, kidney and adipose tissue increased as time elapsed. Postmortem changes of cimetidine concentrations were examined using the tissue samples collected 0, 1 and 2 days after death. There was no statistical significance in the postmortem changes in cimetidine concentrations in the body tissues over the two-day period of examination. The experimental results indicated that the muscle, lung and spleen together can serve as samples for toxicological analysis to evaluate the effect of cimetidine, regardless of various postmortem factors, including the availability of blood.

UR - http://www.scopus.com/inward/record.url?scp=0028298427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028298427&partnerID=8YFLogxK

M3 - Article

C2 - 8196211

AN - SCOPUS:0028298427

VL - 48

SP - 75

EP - 78

JO - Japanese Journal of Legal Medicine

JF - Japanese Journal of Legal Medicine

SN - 0047-1887

IS - 2

ER -